mupirocin and Mouth-Neoplasms

mupirocin has been researched along with Mouth-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for mupirocin and Mouth-Neoplasms

ArticleYear
Erysipelas as a superinfection of an oral lymphangioma.
    The Journal of pediatrics, 2014, Volume: 165, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Erysipelas; Female; Humans; Lymphangioma, Cystic; Mouth Neoplasms; Mupirocin; Streptococcus pyogenes; Superinfection

2014
Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2007, Volume: 65, Issue:11

    Elimination of methicillin-resistant Staphylococcus aureus (MRSA) is of critical importance in oral and maxillofacial surgery because control is very difficult once infection of an oral tumor or oral wound with MRSA is established.. We retrospectively investigated the risk factors for acquiring MRSA in 518 patients with oral cancer among 1,877 inpatients in our department between 1984 and 2005.. The patients with oral cancer demonstrated a high rate of MRSA colonization and infection (77.8%) relative to the population as a whole with MRSA isolated percentage in our department after 1991. The risk factors for MRSA in oral cancer patients are also related to systemic diseases and physiological and iatrogenic conditions, including cerebrovascular diseases (77.8%), peripheral arterial catheterization (69.2%), diabetes (50.0%), tracheotomy (50.0%), renal failure (50.0%), long-term broad-spectrum antibiotic use (45.7%), and malnutrition (43.3%). However, the highest risk of MRSA seems to be related to poor hygienic care.. Beginning in 1999, we implemented a strategy for reducing infection by MRSA that included nasal mupirocin ointment for patients at high risk of MRSA; since then, the detection rate has decreased. We suggest that the administration of nasal mupirocin ointment and provision of scrupulous hygienic care for high-risk patients are useful and effective measures for decreasing the incidence of MRSA infection.

    Topics: Administration, Intranasal; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheterization, Peripheral; Cerebrovascular Disorders; Colony Count, Microbial; Diabetes Complications; Follow-Up Studies; Humans; Hygiene; Malnutrition; Methicillin Resistance; Mouth Neoplasms; Mupirocin; Ointments; Renal Insufficiency; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Tracheotomy

2007